(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.
Hcw Biologics's earnings in 2026 is -$22,138,462.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$5,394,385, with the lowest HCWB earnings forecast at -$5,182,841, and the highest HCWB earnings forecast at -$5,553,044. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$4,944,853, with the lowest HCWB earnings forecast at -$4,750,937, and the highest HCWB earnings forecast at -$5,090,290.
In 2028, HCWB is forecast to generate -$3,933,406 in earnings, with the lowest earnings forecast at -$3,779,155 and the highest earnings forecast at -$4,049,094.